MicroTech Medical (Hangzhou) Co., Ltd.
MicroTech Medical (Hangzhou) Co., Ltd., a leading player in the medical device industry, is headquartered in Hangzhou, China. Founded in 2000, the company has established itself as a pioneer in the development and manufacturing of innovative diabetes management solutions, including insulin delivery systems and continuous glucose monitoring devices. With a strong presence in both domestic and international markets, MicroTech Medical is renowned for its commitment to quality and technological advancement. The company’s core products are distinguished by their user-friendly design and precision, catering to the needs of patients and healthcare professionals alike. Recognised for its significant contributions to diabetes care, MicroTech Medical continues to enhance its market position through ongoing research and development, solidifying its reputation as a trusted name in the medical technology sector.
DitchCarbon Score
How does MicroTech Medical (Hangzhou) Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
MicroTech Medical (Hangzhou) Co., Ltd.'s score of 28 is higher than 55% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
MicroTech Medical (Hangzhou) Co., Ltd.'s reported carbon emissions
In 2023, MicroTech Medical (Hangzhou) Co., Ltd. reported total carbon emissions of approximately 1,609,670 kg CO2e, comprising 8,370 kg CO2e from Scope 1 and 1,601,900 kg CO2e from Scope 2 emissions. This marks a significant increase from 2022, where the company recorded total emissions of about 1,129,470 kg CO2e, with Scope 1 emissions at 820 kg CO2e and Scope 2 emissions at 1,129,380 kg CO2e. MicroTech Medical has set ambitious climate commitments, aiming to reduce its direct GHG emissions (Scope 1) by 50% from a 2021 baseline by 2030. Additionally, the company plans to cut its indirect GHG emissions (Scope 2) by 40% from the same baseline by 2030. Looking further ahead, MicroTech Medical is committed to achieving net zero emissions for both Scope 1 and Scope 2 by 2050. The company’s emissions data is not cascaded from any parent organisation, indicating that these figures are independently reported. As part of its sustainability strategy, MicroTech Medical is actively working towards these reduction targets, reflecting a commitment to addressing climate change and minimising its environmental impact.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 820 | 0,000 |
| Scope 2 | 1,129,380 | 0,000,000 |
| Scope 3 | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
MicroTech Medical (Hangzhou) Co., Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
